1. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients

   • Yassine Yachou
   • Abdeslem El Idrissi
   • Said Ait Benali

   COVID-19 28 July 2020 Pages: 2657 - 2669

   

2. Dyspnea perception and neurological symptoms in non-severe COVID-19 patients

   • Josuel Ora
   • Claudio Liguori
   • Paola Rogliani

   COVID-19 30 July 2020 Pages: 2671 - 2674

3. Impact of COVID-19 on neurological manifestations: an overview of stroke presentation in pandemic

   • Nida Fatima
   • Maher Saqqur
   • Ashfaq Shuaib

   COVID-19 06 August 2020 Pages: 2675 - 2679

   

4. Acutely altered mental status as the main clinical presentation of multiple strokes in critically ill patients with COVID-19

   • Carolina Díaz-Pérez
   • Carmen Ramos
   • José Vivancos

   COVID-19 17 August 2020 Pages: 2681 - 2684

   

5. Neurological manifestations of neurofibromatosis: a review

   • Michael Bayat
   • Allan Bayat

   Review Article 01 May 2020 Pages: 2685 - 2690

   

6. Peripheral neuropathy in Parkinson’s disease

   • Dion A. Paul
   • Abdul Rehman M. Qureshi
   • Abdul Qayyum Rana

   Review Article 01 May 2020 Pages: 2691 - 2701

7. Improving care of chronic pain patients with spinal cord stimulator therapy amidst the opioid epidemic

   • Mayank Gupta
   • Alaa Abd-Elsayed
   • Nebojsa Nick Knezevic

   Review Article 04 May 2020 Pages: 2703 - 2710

8. Pearls and pitfalls in brain functional analysis by event-related potentials: a narrative review by the Italian Psychophysiology and Cognitive Neuroscience Society on methodological limits and clinical reliability—part I

   • Marina de Tommaso
   • Viviana Betti
   • Massimiliano Valeriani

   Review Article 09 May 2020 Pages: 2711 - 2735

   

9. Post-Traumatic Stress Disorder After Traumatic Brain Injury—A Systematic Review and Meta-Analysis

   • Afrim Iljazi
   • Håkan Ashina
   • Sait Ashina

   Review Article 15 May 2020 Pages: 2737 - 2746

   

10. Effects of saffron (Crocus sativus L.) on cognitive function. A systematic review of RCTs

    • Konstantinos I. Avgerinos
    • Christos Vrysis
    • Dimitrios Kapogiannis

    Review Article 23 May 2020 Pages: 2747 - 2754

    

11. Comparison between optic neuritis associated with antibody against myelin oligodendrocyte glycoprotein and presumed idiopathic optic perineuritis

    • Yeonji Jang
    • Sung-Min Kim
    • Jong Hoon Shin

    Original Article 10 April 2020 Pages: 2755 - 2760

    

12. Theory of mind in Parkinson’s disease: evidences in drug-naïve patients and longitudinal effects of dopaminergic therapy

    • Eleonora Del Prete
    • Pierpaolo Turcano
    • Roberto Ceravolo

    Original Article 10 April 2020 Pages: 2761 - 2766

13. Glucocorticoid receptor mutations and clinical sensitivity to glucocorticoid in Chinese multiple sclerosis patients

    • Tian Song
    • Haoxiao Chang
    • Xinghu Zhang

    Original Article Open access 10 April 2020 Pages: 2767 - 2771

    

14. Caregivers of people with disorders of consciousness: which burden predictors?

    • Francesca G. Magnani
    • Matilde Leonardi
    • Davide Sattin

    Original Article 11 April 2020 Pages: 2773 - 2779

15. Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study

    • Marcello Moccia
    • Jessica Frau
    • Vincenzo Brescia Morra

    Original Article 12 April 2020 Pages: 2781 - 2792

    

16. Serum cystatin C is associated with carotid atherosclerosis in patients with acute ischemic stroke

    • Jing Ren
    • Xiaoyu Dong
    • Jianfei Nao

    Original Article 12 April 2020 Pages: 2793 - 2800

    

17. Sensory function in headache: a comparative study among patients with cluster headache, migraine, tension-type headache, and asymptomatic subjects

    • Miguel Malo-Urriés
    • Elena Estébanez-de-Miguel
    • César Hidalgo-García

    Original Article 13 April 2020 Pages: 2801 - 2810

    

18. A new test of action verb naming: normative data from 290 Italian adults

    • Costanza Papagno
    • Alessandra Casarotti
    • Davide Crepaldi

    Original Article 13 April 2020 Pages: 2811 - 2817

19. Aspirin or anticoagulation after cryptogenic stroke with patent foramen ovale: systematic review and meta-analysis of randomized controlled trials

    • Michele Romoli
    • David Giannandrea
    • Paolo Calabresi

    Original Article 18 April 2020 Pages: 2819 - 2824

    

20. Differences in correlations of depression and anhedonia with cardiovascular sympathetic functions during a head-up tilt test in drug-naïve Parkinson’s disease patients

    • Hidetomo Murakami
    • Tomotaka Shiraishi
    • Yasuyuki Iguchi

    Original Article 19 April 2020 Pages: 2825 - 2830

    

21. Understanding patients’ and caregivers’ perspectives and educational needs in Parkinson’s disease: a multi-ethnic Asian study

    • Xing Yan Choo
    • Shen-Yang Lim
    • Ai Huey Tan

    Original Article 20 April 2020 Pages: 2831 - 2842

    

22. Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS study

    • Giancarlo Comi
    • Carlo Pozzilli
    • Maria Trojano

    Original Article Open access 21 April 2020 Pages: 2843 - 2851

    

23. Susceptibility-weighted imaging and transcranial Doppler ultrasound in patients with cerebral small vessel disease

    • Petrenko Mykola
    • Natalia Svyrydova
    • Yevgen Trufanov

    Original Article 22 April 2020 Pages: 2853 - 2858

    

24. Different clinical characteristics of longitudinally extensive transverse myelitis with and without connective tissue disorders: a single-center retrospective study

    • Qiu-Xia Zhang
    • Chen-Na Huang
    • Li Yang

    Original Article 23 April 2020 Pages: 2859 - 2866

    

25. Assessing the relationship between non-motor symptoms and health-related quality of life in Parkinson’s disease: a retrospective observational cohort study

    • Tatsuya Ueno
    • Tomoya Kon
    • Masahiko Tomiyama

    Original Article 23 April 2020 Pages: 2867 - 2873

26. Mendelian randomization study to evaluate the effects of interleukin-6 signaling on four neurodegenerative diseases

    • Haihua Zhang
    • Tao Wang
    • Guiyou Liu

    Original Article 24 April 2020 Pages: 2875 - 2882

27. The impact of freezing of gait on functional dependency in Parkinson’s disease with regard to motor phenotype

    • Diego Santos-García
    • Teres de Deus-Fonticoba
    • on behalf of the COPPADIS Study Group

    Original Article 24 April 2020 Pages: 2883 - 2892

    

28. Early putamen hypertrophy and ongoing hippocampus atrophy predict cognitive performance in the first ten years of relapsing-remitting multiple sclerosis

    • Maria Elisa Morelli
    • Sara Baldini
    • Paolo Manganotti

    Original Article 24 April 2020 Pages: 2893 - 2904

    

29. Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study

    • Francesco Patti
    • Clara Grazia Chisari
    • on behalf of the SA.FE. group

    Original Article 25 April 2020 Pages: 2905 - 2913

    

30. Cerebrospinal fluid MFG-E8 as a promising biomarker of amyotrophic lateral sclerosis

    • Biying Yang
    • Yongshun Wu
    • Xiaolei Shi

    Original Article 27 April 2020 Pages: 2915 - 2920

    

31. An APP mutation family exhibiting white matter hyperintensities and cortical calcification in East China

    • Yang Yi
    • Ye Xiaobin
    • Cai Huaying

    Original Article 28 April 2020 Pages: 2921 - 2928

    

32. Long-term effectiveness of levodopa-carbidopa intestinal gel on motor and non-motor symptoms in advanced Parkinson’s disease: results of the Italian GLORIA patient population

    • Angelo Antonini
    • Pietro Marano
    • Leonardo Lopiano

    Original Article Open access 28 April 2020 Pages: 2929 - 2937

    

33. Experience with rituximab therapy in a real-life sample of multiple sclerosis patients

    • Angelo Bellinvia
    • Elio Prestipino
    • Maria P. Amato

    Original Article 29 April 2020 Pages: 2939 - 2945

34. Sensitivity of magnetic resonance tomographic angiography for detecting the degree of neurovascular compression in trigeminal neuralgia

    • Yun-bo Hao
    • Wei-jie Zhang
    • Wen-bin Wei

    Original Article Open access 29 April 2020 Pages: 2947 - 2951

    

35. MyomiRNAs and myostatin as physical rehabilitation biomarkers for myotonic dystrophy

    • Valentina Pegoraro
    • Paola Cudia
    • Corrado Angelini

    Original Article 29 April 2020 Pages: 2953 - 2960

    

36. Appropriateness, safety, and effectiveness of “drip and ship” teleconsultation model in Southeastern Tuscany: a feasibility study

    • Simone Gallerini
    • Luca Marsili
    • Roberto Marconi

    Brief Communication 08 May 2020 Pages: 2961 - 2965

    

37. Anoctamin 5 (ANO5) muscular dystrophy—three different phenotypes and a new histological pattern

    • Ferran Seguí
    • Lidia Gonzalez-Quereda
    • José César Milisenda

    Brief Communication 12 May 2020 Pages: 2967 - 2971

    

38. Giovanni Mingazzini (1859–1929) and his opposition to Pierre Marie’s conception of motor aphasia

    • Francesco Brigo
    • Raffaele Nardone

    History of Neurology 13 July 2020 Pages: 2973 - 2976

    

39. Mental health and quality of life in patients with cervical dystonia

    • Tomoyuki Kawada

    Letter to the Editor 22 April 2020 Pages: 2977 - 2977

40. Comment on “Increased Epicardial Fat Thickness and Carotid Intima–Media Thickness in Migraine Patients”

    • Erkan Cure
    • Medine Cumhur Cure

    Letter to the Editor 23 April 2020 Pages: 2979 - 2980

41. An unusual case of anti-basal ganglia encephalitis showing polyradiculoneuritis features

    • Valentina Favoni
    • Michela Crisci
    • Roberto Michelucci

    Letter to the Editor 24 April 2020 Pages: 2981 - 2983

    

42. The hyperchoic rim of the normal nerve in ultrasound: how significant is it?

    • Daniele Coraci
    • Silvia Giovannini
    • Luca Padua

    Letter to the Editor 01 May 2020 Pages: 2985 - 2987

    

43. NGS-based detection of a novel mutation in PRKCG (SCA14) in sporadic adult-onset ataxia plus dystonic tremor

    • Vittorio Riso
    • S. Rossi
    • G. Silvestri

    Letter to the Editor 05 May 2020 Pages: 2989 - 2991

    

44. Olfactory hypoplasia and oculomotor nerve hypoplasia in a patient with Wolf-Hirschhorn syndrome

    • Hee Kyung Yang
    • Jae Hyoung Kim
    • Jeong-Min Hwang

    Letter to the Editor 18 May 2020 Pages: 2993 - 2995

    

45. Advance care planning and mental capacity in ALS: a current challenge for an unsolved matter

    • Barbara Poletti
    • Laura Carelli
    • Vincenzo Silani

    Letter to the Editor 20 May 2020 Pages: 2997 - 2998

46. A treatable case of autoimmune GFAP astrocytopathy presenting chronic progressive cognitive impairment

    • Takahiro Natori
    • Kazumasa Shindo
    • Yoshihisa Takiyama

    Letter to the Editor 23 May 2020 Pages: 2999 - 3002

    

47. A case of very prolonged new onset refractory status epilepticus (NORSE) with no evidence of autoimmune activation and a good neurological recovery

    • Monica Ferlisi
    • Elena Greco
    • Paolo Zanatta

    Letter to the Editor 27 May 2020 Pages: 3003 - 3006

    

48. Long-term overdose of cold syrup induced hemichorea-hemiballismus

    • Kuan-Ying Li
    • Ching-Fang Chien
    • Li-Min Liou

    Letter to the Editor 29 May 2020 Pages: 3007 - 3008

49. Pediatric anti-HMGCR necrotizing myopathy: diagnostic challenges and literature review

    • Daniele Velardo
    • Irene Faravelli
    • Giacomo Pietro Comi

    Letter to the Editor 01 June 2020 Pages: 3009 - 3013